Trials / Completed
CompletedNCT02851615
Improving Self-Management in Adolescents With Sickle Cell Disease
SCThrive: Improving Self-Management in Adolescents With Sickle Cell Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- All
- Age
- 13 Years – 21 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine the feasibility and acceptability of SCThrive, a an innovative, technology-enhanced, group self-management intervention that uses a mixed in-person and online format and supported by a tailored mHealth tool, iManage. The study will also evaluate the initial efficacy of SCThrive for increasing behavioral activation (BA) in adolescents with Sickle Cell Disease (SCD) ages 13 to 21. The investigators hypothesize that participants in the SCThrive group will show greater BA (primary outcome) at post-treatment than the attention control group, and that participants in the SCThrive group will continue to show significantly greater BA at the six week follow-up compared to the attention control group. Investigators will also explore whether SCThrive is associated with greater improvements in self-management behaviors and quality of life (secondary outcome) compared to attention control at the six-week follow-up assessment.
Detailed description
The objective of this study is to determine the feasibility and acceptability of SCThrive, a an innovative, technology-enhanced, group self-management intervention that uses a mixed in-person and online format and supported by a tailored mHealth tool, iManage. The study will also evaluate the initial efficacy of SCThrive for increasing behavioral activation (BA) in adolescents with Sickle Cell Disease (SCD) ages 13 to 21.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SCThrive Intervention for Adolescents with SCD | Chronic Disease Self-Management Program |
Timeline
- Start date
- 2016-03-31
- Primary completion
- 2018-03-31
- Completion
- 2018-03-31
- First posted
- 2016-08-01
- Last updated
- 2024-03-04
- Results posted
- 2021-03-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02851615. Inclusion in this directory is not an endorsement.